University of Virginia Medical Center Obstetrics and Gynecology

Topics

• Endometrial and Cervical Cancer Treatments 195
• Ovarian cancer diagnosis and treatment 181
• Menopause: Health Impacts and Treatments 98
• Pelvic floor disorders treatments 71
• Endometriosis Research and Treatment 59
• Gestational Diabetes Research and Management 47
• Prenatal Screening and Diagnostics 47
• Pregnancy and preeclampsia studies 46
• Maternal and fetal healthcare 39
• Cervical Cancer and HPV Research 37
• Cancer Immunotherapy and Biomarkers 34
• Reproductive Biology and Fertility 30

Most cited

1. Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics.

   Cancer cell · 2025 · 196 citations · Amir Jazaeri

2. Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial.

   Lancet (London, England) · 2024 · 348 citations · Linda Duska

3. Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.

   The New England journal of medicine · 2023 · 405 citations · Linda Duska

4. Enhanced recovery after surgery (ERAS®) society guidelines for gynecologic oncology: Addressing implementation challenges - 2023 update.

   Gynecologic oncology · 2023 · 160 citations · Rebecca Stone

5. Noninvasive prenatal screening (NIPS) for fetal chromosome abnormalities in a general-risk population: An evidence-based clinical guideline of the American College of Medical Genetics and Genomics (ACMG).

   Genetics in medicine : official journal of the American College of Medical Genetics · 2023 · 177 citations · Jeffrey Dungan

6. Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial.